403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Knight Therapeutics Inc.
(MENAFN- Baystreet) 10:09 AM EST - Knight Therapeutics Inc. : Today reported financial results for its first quarter ended March 31, 2025. Revenues were $88,076, an increase of $1,472 or 2% over the same period in prior-year. Net income was $2,185, compared to a net loss $4,546 in the same period in prior-year. Knight Therapeutics Inc.
shares T are trading down $0.29 at $5.78.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
- Global Financial Crime Prevention Leader Feedzai Acquires Demyst To Break Down Data Silos And Accelerate Risk Decisions
- Edgen Launches AI Super App, Democratizing Institutional-Grade Crypto Market Intelligence
- Canelo Álvarez Joins 1Win As Global Ambassador After Historic Title Victory
- Biomatrix Launches Ipoy: Pioneering Identity-Driven Gamefi In The AI-Powered Web3 Era
- FBS Analysts Expect Market Recovery After Recent Bitcoin Decline
- Shardeum Mainnet Goes Live, Debuting Autoscaling L1 After Record Testnet Validator Participation
More Story
Comments
No comment